Načítá se...
Angiogenesis and liver fibrosis
Recent data indicate that hepatic angiogenesis, regardless of the etiology, takes place in chronic liver diseases (CLDs) that are characterized by inflammation and progressive fibrosis. Because anti-angiogenic therapy has been found to be efficient in the prevention of fibrosis in experimental model...
Uloženo v:
| Vydáno v: | World J Hepatol |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Baishideng Publishing Group Inc
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4381164/ https://ncbi.nlm.nih.gov/pubmed/25848465 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4254/wjh.v7.i3.377 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|